increasing semaglutide What Is Semaglutide? A Beginner's Guide to Weight Loss, Diabetes & How It Works Weight-loss drugs are becoming more

Learn more and contact us today.

Obesity has emerged as one of the leading global drivers of gastrointestinal and metabolic disease, contributing substantially to the burden of metabolic dysfunction-associated steatotic liver disease (MASLD), gastroesophageal reflux disease (GERD), Barrett's esophagus, pancreatitis, colorectal neoplasia, and obesity-associated malignancies

A recent cohort study has illuminated significant disparities in the fulfillment of prescriptions for glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of medications pivotal in managing

Personalized plans to reduce appetite

Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new